Liposomal Formulation of a Gold(III) Metalloantibiotic: A Promising Strategy Against Antimicrobial Resistance.

Alejandro Llamedo,Pablo Rodríguez,Yaiza Gabasa,Raquel G. Soengas,Humberto Rodríguez-Solla,David Elorriaga,Francisco Javier García Alonso,Sara M. Soto
DOI: https://doi.org/10.1039/d4dt01867b
IF: 4
2024-08-31
Dalton Transactions
Abstract:A novel lipoformulation was developed by encapsulating cationic (S^C)-cyclometallated gold(III) complex [Au(dppta)(N2Py-PZ-dtc)]+ (AuPyPZ) in liposomes. The liposomal form of compound AuPyPZ has a bactericidal action similar to that of the free drug without any appreciable effect on the viability of mammalian cells. Furthermore, the nanoformulation reduce metalloantibiotic-induced inhibition of hERG and the inhibition of cytochromes, significantly decreasing the potential liabilities of the metallodrug. The obtained metalloantibiotic liposomal formulation shows high stability and suitable properties for drug delivery, representing an effective strategy to fight against drug-resistant bacteria.
chemistry, inorganic & nuclear
What problem does this paper attempt to address?